Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

NCT01596647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors, Excluding Breast Cancer

Interventions

DRUG: caffeine
DRUG: diclofenac
DRUG: omeprazole
DRUG: midazolam
DRUG: TKI258

Sponsor

Novartis Pharmaceuticals